LeonaBio, Inc.
LONA
$7.04
-$0.98-12.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -6.01% | -26.33% | -36.08% | -28.85% | -16.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.38% | -45.58% | -64.68% | -64.89% | -52.32% |
| Operating Income | 5.38% | 45.58% | 64.68% | 64.89% | 52.32% |
| Income Before Tax | -136.34% | -62.28% | -8.94% | 65.46% | 47.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -136.34% | -62.28% | -8.94% | 65.46% | 47.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -136.34% | -62.28% | -8.94% | 65.46% | 47.24% |
| EBIT | 5.38% | 45.58% | 64.68% | 64.89% | 52.32% |
| EBITDA | 5.42% | 46.14% | 65.34% | 65.46% | 52.74% |
| EPS Basic | -27.51% | -0.09% | 15.48% | 66.04% | 47.93% |
| Normalized Basic EPS | 51.41% | 59.32% | 64.49% | 65.35% | 52.38% |
| EPS Diluted | -27.51% | -0.09% | 15.48% | 66.04% | 47.93% |
| Normalized Diluted EPS | 51.41% | 59.32% | 64.49% | 65.35% | 52.38% |
| Average Basic Shares Outstanding | 234.99% | 108.39% | 11.11% | 1.93% | 1.63% |
| Average Diluted Shares Outstanding | 234.99% | 108.39% | 11.11% | 1.93% | 1.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |